• Latest Posts
In Depth 22 Jul 2022

The coming of age story of RNAi technology

A Year to Remember: The Biggest European Biotech News in 2020

Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B

More News! 19 Jul 2019

Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M

UK Biotech Settles Lawsuit on the First RNAi Drug

In Depth 23 Jan 2018

Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?

In Depth 19 Sep 2017

RNA as a Therapy: Reviewing the Future Generation of Therapeutics

CRISPR meets RNAi: a whole new Targeted Therapy